Cargando…
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trial...
Autor principal: | Srivastava, Padma |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859581/ https://www.ncbi.nlm.nih.gov/pubmed/20436740 http://dx.doi.org/10.4103/0972-2327.61270 |
Ejemplares similares
-
Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010) -
Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
por: Al-Shahi Salman, Rustam, et al.
Publicado: (2019) -
Antithrombotic Therapy in the Prevention of Stroke
por: Bir, Shyamal, et al.
Publicado: (2021) -
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention
por: Weber, Ralph, et al.
Publicado: (2010)